# The COOPerative Establishment for Necessary Investigation in Clinical Outcome After Stenting

> **NCT01534221** · PHASE4 · UNKNOWN · sponsor: **Zealand University Hospital** · enrollment: 5100 (estimated)

## Conditions studied

- Ischemic Heart Disease

## Interventions

- **DEVICE:** Biomatrix drug eluting stent

## Key facts

- **NCT ID:** NCT01534221
- **Lead sponsor:** Zealand University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-03
- **Primary completion:** 2020-03
- **Final completion:** 2021-03
- **Target enrollment:** 5100 (ESTIMATED)
- **Last updated:** 2012-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01534221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01534221, "The COOPerative Establishment for Necessary Investigation in Clinical Outcome After Stenting". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01534221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*